UX-016

N/A

Report date: 2026/04/07 20:00:20
NME

Base Information

Drug NameUX-016
Drug Alias NameSialic Acid-C16 ProdrugUX016UX-016
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsHereditary inclusion body myopathy (HIBM)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesUltragenyx Pharmaceutical Inc
China Registration ClassN/A

Develop Information

Active CompaniesUltragenyx Pharmaceutical Inc
Inactive CompaniesN/A
Active IndicationsHereditary inclusion body myopathy (HIBM)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A